C. Farquharson

发表

Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man

A. Struthers, J. Sim, C. Farquharson, 2004, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure.

A. Struthers, C. Farquharson, 2002, Journal of the American College of Cardiology.

Reversible hypertension following coeliac disease treatment: the role of moderate hyperhomocysteinaemia and vascular endothelial dysfunction

R. Macwalter, T. MacDonald, A. Struthers, 2002, Journal of Human Hypertension.

Angiotensin II receptor blockers in chronic heart failure - Not as ELITE as expected!

A. Struthers, C. Farquharson, 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.

A. Struthers, C. Farquharson, 2000, Circulation.

Effect of spironolactone on C-reactive protein levels in patients with heart disease.

K. Yee, A. Struthers, V. Godfrey, 2007, International journal of cardiology.

Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure

A. Struthers, A. Hill, J. Belch, 2002, Circulation.

Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy.

A. Struthers, C. Farquharson, 2002, Clinical science.

Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extrasystoles but does not change endothelial function or heart rate variability in chronic heart failure

A. Struthers, C. Farquharson, 2002, Heart.

Adverse Cardiac Effects of Salt With Fludrocortisone in Hypertension

T. MacDonald, A. Struthers, R. Jung, 2001, Hypertension.